Merck & Co Inc (NYSE: MRK) Q4 2019 Earnings Call Transcript
Merck & Co Inc (NYSE: MRK) Q4 2019 Earnings Conference Call February 05, 2020 Corporate Participants: Peter Dannenbaum — Vice President of Investor Relations Kenneth C. Frazier — Chairman…
Market News
Merck & Co. (MRK) Q4 earnings beat estimates, revenue slightly misses
Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings for the fourth quarter of 2019. However, the company’s sales slightly missed the forecast.…
Market News
Where does Merck (MRK) stand in the cancer-drug race?
Shares of Merck and Co. (NYSE: MRK) this week pared some of their recent gains even as the ex-dividend date approaches. While most investors wouldn’t…
Market News
Merck’s (MRK) Q3 results beat estimates; sales boosted by oncology and vaccines
Merck (NYSE: MRK) surpassed analysts’ expectations for revenue and earnings in the third quarter of 2019, sending the shares climbing 2.5% in premarket hours on…
ADVERTISEMENT